REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. Profile Updated: February 20, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Ambulatory Health Care Services sector. It was established on August 31, 2021. From the latest financial highlights, Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. reported a net sales revenue drop of 11.83% in 2021. A negative growth of 17.46% was recorded in its total assets. Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S.’s net profit margin increased by 141.24% in 2021.

Headquarters
Av Cr 9 # 115 - 06 Of 2604
Bogota D.C.; Bogota D.C; Postal Code: 1002

Contact Details: Purchase the Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. report to view the information.
Incorporation Date:
August 31, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Instituto de Alivio del Dolor y Medicina Paliativa Indol S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-11.83%
Total operating revenue
-11.83%
Operating profit (EBIT)
1103.79%
Net Profit (Loss) for the Period
902.13%
Total assets
-17.46%
Total equity
105.41%
Operating Profit Margin (ROS)
170.47%
Net Profit Margin
141.24%
Return on Equity (ROE)
31.32%
Quick Ratio
55.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?